缺铁性贫血是一种世界范围的常见病,约占世界人口的10～20%,不同年龄与性别均可发病,妇女发病率更高,我国七岁以下儿童发病率占40%。缺铁性贫血除病因治疗外,均需补充铁剂。口服铁剂是治疗缺铁性贫血最为有效和最为常用的药物,因此,在使用口服铁剂过程中应注意其配伍变化,以免影响铁的吸收和利用,达不到治疗目的。现就口服铁剂的有关配伍问题,简述如下: Iron deficiency anemia is a worldwide common disease accounting for 10-20% of the world’s population. It can be morbidly affected by different age and gender. The incidence of women is even higher, and the incidence of children under the age of seven accounts for 40%. Iron deficiency anemia in addition to the cause of treatment, are required to add iron. Oral iron is the most effective and the most commonly used drugs for the treatment of iron deficiency anemia. Therefore, we should pay attention to the changes of compatibility in the process of using oral iron so as to avoid affecting the absorption and utilization of iron and failing to achieve the therapeutic goal. Oral iron preparations now on the compatibility issues, summarized as follows: